 |
|
Related Pages |
|
|
|
What Is a Clinical Trial?
A basic description of the reason for, and the kinds of, clinical trials.
Cancer Vaccines
Cancer vaccines are intended either to treat existing cancers (therapeutic vaccines) or to prevent the development of cancer (prophylactic vaccines). Fact Sheet 7.56
|
|
|
|
|
|
Helpful Links
The following links will take you to other information on the National Cancer Institute Web site about cancer vaccines:
Cancer Vaccines
(Reviewed: 03/17/2009) - Cancer vaccines are intended either to treat existing cancers (therapeutic vaccines) or to prevent the development of cancer (prophylactic vaccines). Fact Sheet 7.56
HPV (Human Papillomavirus) Vaccines for Cervical Cancer
(Posted: 06/08/2006, Updated: 11/07/2007) - A collection of material about HPV and vaccines designed to prevent infections from certain types of the virus that may lead to cervical cancer.
Biological Therapy
(Posted: 12/29/2004) - An introduction to biological therapy to help patients prepare to receive it for cancer treatment or managing side effects.
Biological Therapies for Cancer: Questions and Answers
(Reviewed: 06/13/2006) - A fact sheet that provides an overview of how the immune system functions and describes the actions of biological therapies. National Cancer Institute Fact Sheet 7.2
Terapias biológicas del cáncer: preguntas y respuestas
(Revisión: 02/22/2005) - Una hoja informativa que proporciona una vista general de cómo funciona el sistema inmune y describe las terapias biológicas disponibles. Hoja informativa 7.2s del Instituto Nacional del Cáncer/A fact sheet that provides an overview of how the immune system functions and describes available biological therapies. National Cancer Institute Fact Sheet 7.2s
NCI Pursues Vaccines to Prevent and Treat Cancer
An article in the March 21, 2003, issue of NCI's Benchmarks examines prevention and treatment cancer vaccines. Offers a link to the fact sheet Cancer Vaccine Primer.
New Role for Immune System Player May Help Improve Cancer Vaccines
(Posted: 10/31/2002) - A report in the Nov. 1, 2002, issue of Science suggests a peptide called ß-defensin 2 may be useful in the development of more effective cancer vaccines.
Interferon Superior to a GMK Vaccine in Preventing Melanoma Relapse
(Posted: 05/04/2001, Reviewed: 05/25/2005) - High-dose interferon proved superior to a GMK ganglioside vaccine, a potentially promising cancer therapy, in protecting high-risk patients against a recurrence of their melanoma, according to research from a multicenter clinical trial published in the May 1, 2001, Journal of Clinical Oncology.
Lymphoma Vaccine Enters Large-Scale Clinical Trials
(Posted: 09/27/1999, Reviewed: 05/11/2005) - Results of a lymphoma cancer vaccine study show that there is a clear anti-tumor effect in a small group of patients who were vaccinated over the course of five years, according to researchers at the National Cancer Institute (NCI).
Laboratory of Tumor Immunology and Biology
The Laboratory of Tumor Immunology and Biology conducts research in the areas of tumor immunology, mechanisms of tumor cell-immune cell interactions, and immune mechanisms.
< Previous Section |
